Myeloid-derived suppressor cell (MDSC)-mediated tumor immunosuppressive environments regulated the immunosuppressive environments in a tumor microenvironment (TME), and findings revealed that MDSC development and differentiation could be induced by chemotherapy through IL-13/IL-33-mediated pathway in lung cancer (9). This evidence concerns the gene IL33 and neoplasm.